twenty iddm patients with no or only minor clinical signs of microvascular disease were randomly assigned to 1 year of continuous subcutaneous insulin infusion ( csii ) or unchanged conventional insulin treatment ( cit ) .
C0011854
iddm
C0021641
insulin